Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Clinical trial NCT00836654 · COMPLETED

Trial details

NCT number: NCT00836654
Sponsor: Neovii Biotech
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites

Start date: 2004-09-01
Primary completion: 2006-11-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.